Avra, Inc. Operating as Springs Rejuvenation (AVRN) Reports a +200% Increase in Revenue Post-Merger

Rhea-AI Summary

Avra, Inc. (OTC PINK: AVRN), operating as Springs Rejuvenation, reported a remarkable +200% increase in 4th quarter earnings compared to the 3rd quarter, nearing the total earnings of the previous three quarters combined. This growth follows their recent merger, which is reflected in their annual report. CEO Everett Dickson noted their enhanced marketing efforts, including digital advertising and a new campaign, are contributing to this success. As they open new locations and expand service offerings with advanced equipment, further growth is anticipated.

Positive

• 200% increase in Q4 earnings compared to Q3.
• Earnings almost match total of previous three quarters combined.
• Strong growth expected post-merger.
• Enhanced marketing efforts showing positive impact.

Negative

• None.

ATLANTA, GA, Feb. 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Avra, Inc. (OTC PINK: AVRN), operating as Springs Rejuvenation, (“Springs”), a Chamblee, Georgia based anti-aging and stem cell center focusing on stem cell therapy, announced today a +200% increase in their 4th quarter earnings compared to the 3rd quarter. This is a substantial increase nearly matching All of the 3 previous quarters’ earnings combined, and strong growth is expected to continue. Avra’s annual report, filed on OTC Markets, shows a strong uptick of the company’s earnings post-merger. 

CEO Everett Dickson is quoted as saying, “It’s clear our marketing efforts are beginning to bear fruit. We have been retooling our digital footprint, beta testing several Google ads and launching a ‘boots on the ground’ campaign to increase the recognition of our clinics. We expect this trend to increase as our new locations open and our new C-Arm equipment expands our service offerings.”

About Springs Rejuvenation Inc.

At Springs Rejuvenation, we strive to be at the cutting edge of regenerative medicine and anti-aging research. Our mission is to provide patients with individualized, state-of-the-art treatment, returning each patient to their natural mobility as quickly as possible. 

Our goal is to address the root cause of a patient’s pain, rather than just masking it. We want to help patients achieve whole body health and rejuvenation. This will help them feel stronger, improve mood, look younger, heal faster, and perform at the optimal level. Our patients have found both freedom from pain and improved quality of life.

Our professional staff is uniquely composed of physicians/researchers in the Stem Cell, Anti-Aging research and regenerative medicine, also including sports-related injuries and chronic joint pain.

Our Medical Director & Founder is Dr. Charles A. Pereyra,the founder of Springs Rejuvenation Stem Cell Therapy in Atlanta, GA (since 2018). He is our current lead clinical Physician and an expert in Stem Cell, Anti-Aging research and Regenerative medicine. Dr. Juan Pablo Nieto specializes in sports-related injuries as well as chronic joint pain. Dr. Nieto has expertise and significant experience with diagnostic ultrasound exams as well as joint and tendon injections with PRP, & prolotherapy. His highlights include caring/treating professional athletes: NBA Wizards & D1 level athletes from different multiple sports and presented research at national conferences.

FORWARD-LOOKING STATEMENTS:

This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

For a discussion of these risks and uncertainties, please see our filings with the OTC Markets Group Inc. Our public filings with the OTC Markets Group Inc are available from commercial document retrieval services and at the website maintained by the OTC Markets at https://www.otcmarkets.com/stock/AVRN/disclosure

Company website(s): www.avrabiz.com ; https://springsrejuvenation.com

Company Twitter: @Springsavra

Email: avrabiz21@gmail.com

Phone: 678-387-3515

FAQ

What was Avra Inc's earnings growth for Q4 2022?

Avra Inc. reported a +200% increase in Q4 earnings compared to Q3 2022.

How did the merger affect Avra Inc's financial performance?

The merger significantly boosted Avra Inc's earnings, contributing to a strong uptick reported in their annual report.

What marketing strategies is Avra Inc employing to enhance growth?

Avra Inc is focusing on digital advertising, beta testing Google ads, and launching on-the-ground campaigns to increase clinic recognition.

Is Avra Inc. expecting continued growth in the future?

Yes, Avra Inc. anticipates ongoing growth as new locations open and service offerings expand.

What is Avra Inc's stock symbol?

Avra Inc's stock symbol is AVRN on OTC markets.